The risk factors and prognosis of bilateral primary breast cancer: A comparative study with unilateral breast cancer

Oncology Research

Volumn 19, Issue 3-4, 2011, Pages 171-178

  Wang, Tong ^a   Liu, Hong ^a   Chen, Ke Xin ^a,b   Xun, Pei ^a   Li, Hai Xin ^a,b   Tang, Shou Ching ^a,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^c Virginia Piper Cancer Institute   (United States)

Author keywords

Bilateral breast cancer; Prognosis; Treatment and follow up; Unilateral breast cancer

Indexed keywords

ADULT; ARTICLE; BILATERAL CANCER; BREAST CANCER; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; ONSET AGE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREMENOPAUSE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 79952435692     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504011X12935427587966     Document Type: Article

References (26)

1. Imyanitov, E. N.; Hanson, K. P. Molecular pathogenesis of bilateral breast cancer. Cancer Lett. 191:1-7; 2003.
2. Healey, E. A.; Cook, E. F.; Orav, E. J.; Schnitt, S. J.; Connolly, J. L.; Harris, J. R. Contralateral breast cancer: Clinical characteristics and impact on prognosis. J. Clin. Oncol. 11:1545-1552; 1993.
3. Chaudary, M. A.; Millis, R. R.; Hoskins, E. O.; Halder, M.; Bulbrook, R. D.; Cuzick, J.; Hayward, J. L. Bilateral primary breast cancer: A prospective study of disease incidence. Br. J. Surg. 71:711-714; 1984.
4. Saphner, T.; Tormey, D. C.; Gray, R. Annual hazard rates of recurrence for breast cancer after primary therapy. J. Clin. Oncol. 14:2738-2746; 1996.
5. Newman, L. A.; Sahin, A. A.; Cunningham, J. E.; Bondy, M. L.; Mirza, N. Q.; Vlastos, G. S.; Whitman, G. J.; Brown, H.; Buchholz, T. A.; Lee, M. H.; Singletary, S. E. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer 91(10):1845-1853; 2001.
6. Shahedi, K.; Emanuelsson, M.; Wiklund, F.; Gronberg, H. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma. Cancer 106(6):1237-1242; 2006.
7. Carmichael, A. R.; Bendall, S.; Lockerbie, L.; Prescott, R.; Bates, T. The long-term outcome of synchronous bilat- eral breast cancer is worse than metachronous or unilateral tumours. Eur. J. Surg. Oncol. 28(4):388-391; 2002.
8. Verkooijen, H. M.; Chatelain, V.; Fioretta, G.; Vlastos, G.; Rapiti, E.; Sappino, A. P.; Bouchardy, C.; Chappuis, P. O. Survival after bilateral breast cancer: Results from a population-based study. Breast Cancer Res. Treat. 105(3): 347-357; 2007.
9. Hartman, M.; Czene, K.; Reilly, M.; Bergh, J.; Lagiou, P.; Trichopoulos, D.; Adami, H. O.; Hall, P. Genetic implications of bilateral breast cancer: A population based cohort study. Lancet Oncol. 6(6):377-382; 2005.
10. Nicoletto, M. O.; Donach, M.; De Nicolo, A.; Artioli, G.; Banna, G.; Monfardini, S. BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counseling. Cancer Treat. Rev. 27:295-304; 2001.
11. Steinmann, D.; Bremer, M.; Rades, D.; Skawran, B.; Siebrands, C.; Karstens, J. H.; Dork, T. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br. J. Cancer 85:850-858; 2001.
12. Bergthorsson, J. T.; Ejlertsen, B.; Olsen, J. H.; Borg, A.; Nielsen, K. V.; Barkardottir, R. B.; Klausen, S.; Mouridsen, H. T.; Winther, K.; Fenger, K.; Niebur, A.; Harboe, T. L.; Niebuhr, E. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J. Med. Genet. 38:361-368; 2001.
13. Shibata, A.; Tsai, Y. C.; Press, M. F.; Henderson, B. E.; Jones, P. A.; Ross, R. K. Clonal analysis of bilateral breast cancer. Clin. Cancer Res. 2:743-748. 1996.
14. Lidereau, R.; Soussi, T. Absence of p53 germ-line mutations in bilateral breast cancer patients. Hum. Genet. 89: 250-252; 1992.
15. Bernstein, J. L.; Bernstein, L.; Thompson, W. D.; Lynch, C. F.; Malone, K. E.; Teitelbaum, S. L.; Olsen, J. H.; Anton-Culver, H.; Boice, Jr., J. D.; Rosenstein, B. S.; Børresen-Dale, A-L.; Gatti, R. A.; Concannon, P.; the WECARE Study Group; Haile, R. W. ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Br. J. Cancer 89(8):1513-1516; 2003.
16. Safal, M.; Lower, E. E.; Hasselgren, P. O.; Hungness, E. S.; Gazder, P.; Aron, B.; Shaughnessy, E. A.; Yassin, R. Bilateral synchronous breast cancer and Her-2/neu overexpression. Breast Cancer Res. Treat. 72(3):195-201; 2002.
17. Heron, D. E.; Komarnicky, L. T.; Hyslop, T.; Schwartz, G. F.; Mansfield, C. M. Bilateral breast carcinoma: Risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 88(12):2739-2750; 2000.
18. Kollias, J.; Pinder, S. E.; Denley, H. E.; Ellis, P.; Wencyk, P.; Bell, J. A.; Elston, C. W.; Blamey, R. W. Phenotypic similarities in bilateral breast cancer. Breast Cancer Res. Treat. 85:255-261; 2004.
19. Fisher, B.; Costantino, J. P.; Wickerham, D. L.; Redmond, C. K.; Kavanah, M.; Cronin, W. M.; Vogel, V.; Robidoux, A.; Dimitrov, N.; Atkins, J.; Daly, M.; Wieand, S.; Tan-Chiu, E.; Ford, L.; Wolmark, N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J. Natl. Cancer Inst. 90:1371-1388; 1998.
20. The ATAC Trialists's Group. Arimidex, tamoxifen alone or in combination. Anastrozole alone or in combination with tamoxifen verse tamoxifen alone adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet 359:2131-2139; 2002.
21. Cook, L. S.; White, E.; Schwartz, S. M.; McKnight, B.; Daling, J. R.; Weiss, N. S. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7:382-90; 1996.
22. Heaton, K. M.; Peoples, G. E.; Singketary, S. E.; Feig, B. W.; Ross, M. I.; Ames, F. C.; Buchholz, T. A.; Strom, E. A.; McNeese, M. D.; Hunt, K. K. Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann. Surg. Oncol. 6(1):102-108; 1999.
23. van Sprundel, T. C.; Schmidt, M. K.; Rookus, M. A.; Brohet, R.; van Asperen, C. J.; Rutgers, E. J.; van't Veer, J. L.; Tollenaar, R. A. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br. J. Cancer 93(3):287-292; 2005.
24. Wanebo, H. J.; Senofsky, G. M.; Fechner, R. E.; Kaiser, D.; Lynn, S.; Paradies, J. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann. Surg. 201(6):667-677; 1985.
25. Lee, S. G.; Orel, S. G.; Woo, I. J.; Cruz-Jove, E.; Putt, M. E.; Solin, L. J.; Czerniecki, B. J.; Schnall, M. D. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: Preliminary results. Radiology 226(3):773-778; 2003.
26. Pediconi, F.; Venditti, F.; Padula, S.; Roselli, A.; Moriconi, E.; Giacomelli, L.; Catalano, C.; Passariello, R. CE-magnetic resonance mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer. Radiol. Med. (Torino) 110(1-2):61-68; 2005.